{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:19:07Z","timestamp":1785187147505,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Biotechnology (DBT), India","award":["BT\/MB\/CCMD\/07\/2013"],"award-info":[{"award-number":["BT\/MB\/CCMD\/07\/2013"]}]},{"name":"National Institute of Health","award":["AI100665"],"award-info":[{"award-number":["AI100665"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jcv.2019.05.012","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:59:43Z","timestamp":1559235583000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Pooled nucleic acid testing strategy for monitoring HIV-1 treatment in resource limited settings"],"prefix":"10.1016","volume":"117","author":[{"given":"Boobalan","family":"J","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesha","family":"TR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gomathi","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elakkiya","family":"E","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"D","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugavel","family":"KG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balakrishnan","family":"P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantha","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"SS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumarasamy","family":"N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smith","family":"DM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2019.05.012_bib0005","unstructured":"http:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"issue":"6122","key":"10.1016\/j.jcv.2019.05.012_bib0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.1230413","article-title":"Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment","volume":"339","author":"Bor","year":"2013","journal-title":"Science"},{"issue":"6122","key":"10.1016\/j.jcv.2019.05.012_bib0015","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.1228160","article-title":"High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa","volume":"339","author":"Tanser","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jcv.2019.05.012_bib0020","series-title":"Joint United Nations Programme on HIV\/AIDS, and Joint United Nations Programme on HIV\/Aids. \"90-90-90: An Ambitious Treatment Target to Help End the AIDS Epidemic","year":"2014"},{"issue":"5","key":"10.1016\/j.jcv.2019.05.012_bib0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","author":"Gregson","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.jcv.2019.05.012_bib0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/ciw001","article-title":"Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges","volume":"62","author":"Roberts","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"46","key":"10.1016\/j.jcv.2019.05.012_bib0035","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.15585\/mmwr.mm6446a3","article-title":"Scale-up of HIV viral load monitoring\u2013seven Sub-Saharan African countries","volume":"64","author":"Lecher","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"1","key":"10.1016\/j.jcv.2019.05.012_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00430-012-0249-y","article-title":"Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia","volume":"202","author":"Naeth","year":"2013","journal-title":"Med. Microbiol. Immunol."},{"issue":"8","key":"10.1016\/j.jcv.2019.05.012_bib0045","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/JCM.43.8.3963-3970.2005","article-title":"Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays","volume":"43","author":"Huang","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.jcv.2019.05.012_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jviromet.2009.03.021","article-title":"Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq\u2122 2.0 and an in-house method","volume":"159","author":"Saravanan","year":"2009","journal-title":"J. Virol. Methods"},{"issue":"2","key":"10.1016\/j.jcv.2019.05.012_bib0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/QAI.0b013e3181ba37a7","article-title":"Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection","volume":"53","author":"May","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2019.05.012_bib0060","series-title":"Antiretroviral Therapy for HIV Infection in Adults Adolescents. Recommendations for a Public Health Approach (2010 Revision)","author":"World Health Organisation","year":"2010"},{"issue":"5","key":"10.1016\/j.jcv.2019.05.012_bib0065","doi-asserted-by":"crossref","first-page":"e0127235","DOI":"10.1371\/journal.pone.0127235","article-title":"Durable suppression of HIV-1 after virologic monitoring-based antiretroviral adherence counseling in Rakai, Uganda","volume":"10","author":"Billioux","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2019.05.012_bib0070","series-title":"What\u2019s New in Treatment Monitoring: Viral Load and cd4 Testing","author":"NO, ATION","year":"2017"},{"issue":"3","key":"10.1016\/j.jcv.2019.05.012_bib0075","first-page":"160","article-title":"Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modeling of contribution of DNA and RNA","volume":"16","author":"Parkin","year":"2014","journal-title":"AIDS Rev."},{"key":"10.1016\/j.jcv.2019.05.012_bib0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jviromet.2017.05.007","article-title":"Cost-effective HIV-1 virological monitoring in resource-limited settings using a modified commercially available qPCR RNA assay","volume":"248","author":"Boobalan","year":"2017","journal-title":"J. Virol. Methods"},{"issue":"3","key":"10.1016\/j.jcv.2019.05.012_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/QAI.0b013e31827b4ac8","article-title":"Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy","volume":"62","author":"Wamalwa","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"9","key":"10.1016\/j.jcv.2019.05.012_bib0090","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cid\/civ556","article-title":"Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis","volume":"61","author":"Boender","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2019.05.012_bib0095","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/cid\/cis254","article-title":"Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies","volume":"54","author":"Hamers","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jcv.2019.05.012_bib0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(11)70141-4","article-title":"HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review","volume":"11","author":"Sigaloff","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2019.05.012_bib0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","author":"Gregson","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2019.05.012_bib0110","series-title":"WHO HIV Drug Resistance Report 2012","author":"WHO","year":"2012"},{"issue":"December (1\u20132)","key":"10.1016\/j.jcv.2019.05.012_bib0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jviromet.2013.08.015","article-title":"Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol","volume":"194","author":"Bronze","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2019.05.012_bib0120","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/jmv.22189","article-title":"Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa","volume":"83","author":"Van Zyl","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2019.05.012_bib0125","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1128\/JCM.00118-13","article-title":"A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region only","volume":"51","author":"Aitken","year":"2013","journal-title":"J. Clin. Microbiol."},{"issue":"17","key":"10.1016\/j.jcv.2019.05.012_bib0130","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/QAD.0b013e32828cc8b7","article-title":"Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia","volume":"21","author":"Ferradini","year":"2007","journal-title":"Aids"},{"issue":"9","key":"10.1016\/j.jcv.2019.05.012_bib0135","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cid\/civ556","article-title":"Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis","volume":"61","author":"Boender","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2019.05.012_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1570162X13666150825123750","article-title":"Longitudinal analysis of adherence to first-line antiretroviral therapy: evidence of treatment sustainability from an indian HIV cohort","volume":"14","author":"Shet","year":"2016","journal-title":"Curr. HIV Res."},{"issue":"1","key":"10.1016\/j.jcv.2019.05.012_bib0145","doi-asserted-by":"crossref","first-page":"20243","DOI":"10.7448\/IAS.18.1.20243","article-title":"Lack of awareness of treatment failure among HIV\u20101\u2010infected patients in Guinea\u2010Bissau\u2013a retrospective cohort study","volume":"18","author":"Jespersen","year":"2015","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"10.1016\/j.jcv.2019.05.012_bib0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1473-3099(09)70321-4","article-title":"Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives","volume":"10","author":"Harries","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2019.05.012_bib0155","series-title":"Optimal Pooling Strategies for Laboratory Testing","author":"Williams","year":"2010"},{"issue":"4","key":"10.1016\/j.jcv.2019.05.012_bib0160","doi-asserted-by":"crossref","first-page":"e35401","DOI":"10.1371\/journal.pone.0035401","article-title":"A combined screening platform for HIV treatment failure and resistance","volume":"7","author":"Tilghman","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jcv.2019.05.012_bib0165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcv.2014.05.011","article-title":"A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy","volume":"60","author":"Newman","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.05.012_bib0170","series-title":"The HIV Drug Resistance report-2012","author":"World Health Organization","year":"2012"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219301313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219301313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:35:36Z","timestamp":1563446136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653219301313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"alternative-id":["S1386653219301313"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2019.05.012","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pooled nucleic acid testing strategy for monitoring HIV-1 treatment in resource limited settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2019.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}